Thermo Fisher Scientific Logo
      Video home
      close menu
      Video home
      close
      • Home
      • Antibodies Videos
      • Bioprocessing Videos
      • Cancer Research Videos
      • Cell Culture Videos
      • Cell & Gene Therapy Videos
      • Clinical Microbiology Videos
      • Digital Science Videos
      • DNA & RNA Extraction & Analysis Videos
      • Electron Microscopy
      • Environmental Videos
      • Food and Beverage Videos
      • Genome Editing Videos
      • Manufacturing & Processing Videos
      • Mass Spectrometry Videos
      • PCR Videos
      • Protein Biology Videos
      • Radiation Detection & Measurement Videos
      • Real-Time PCR Videos
      • Sequencing Videos
      • Spectroscopy, Elemental & Isotope Analysis Videos
      • Stem Cell Research

      Dry Powder Media Manufacturing Grand Island Expansion

      1:40

      • Share on Facebook
      • Tweet this video
      • Share on LinkedIn
      • Share via Email
      Description
      Related Videos

      Take a video tour of our newly expanded dry powder media manufacturing facility in Grand Island, New York. The expansion has added more than 45,000 square feet of Animal Origin Free (AOF) manufacturing space to help meet the increasing global demand for cell culture media. This $76 million investment increases the site’s capacity to produce critical raw materials used in the development and manufacturing of vaccines and biologic therapies. The expansion opened in August 2022 and has added more than 45,000 square feet of Animal Origin Free (AOF) manufacturing space. This includes manufacturing of Thermo Fisher’s Advanced Granulation Technology (AGT) format and other AOF Dry Powder Media (DPM) products. With this expansion, the Grand Island site provides the redundant capacity to support global supply of media and further extends the site’s capabilities to produce the high-quality technology and materials needed for the development and commercial manufacturing of important medicines, including for COVID-19 vaccines. The Grand Island expansion is part of Thermo Fisher’s $650 million multi-year investment, announced in 2021, to ensure flexible, scalable, and reliable bioprocessing production capacity for its customers.

      View More
      View Less
      Take advantage of our expanded capacity for your next large-scale media manufacturing project. Learn more today.

      Share

      • Share on Facebook
      • Tweet this video
      • Share on LinkedIn
      • Share via Email
      •  
      •  
      •  
      •  
      •  
      Brands
      • Thermo Scientific
      • Applied Biosystems
      • Invitrogen
      • Fisher Scientific
      • Unity Lab Services
      Shopping Tool
      • Product Selection Guides - US
      • Quick Order - US
      • Redeem a Quote
        * Please enter a valid quote
      • New Products
      • Promotions
      • Mobile & Desktop Apps
      • Shared Lists
      eSolutions
      • eProcurement
      • Supply Center
      • Instrument Management
      Support
      • Order Support
      • Training
      • Webinars
      • Blog
      • Social Media
      • Contact Us
      • Report a Site Issue
      Thermo Fisher Scientific
      • About Us
      • Careers
      • Investors
      • News
      • Responsibility
      • Trademarks
      United States
      • Terms & Conditions
      • Privacy Information Center
      • Price & Freight Policy

       

      Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.

      Ok

      Share this video

      Embed

      Size: x pixels